[6-[2-(3-fluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamic acid;2,2,2-trifluoroacetic acid
C24H16F4N4O6 — CID 68656422
Data last refreshed: (MolForge compound catalog, from PubChem)
About [6-[2-(3-fluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamic acid;2,2,2-trifluoroacetic acid
[6-[2-(3-fluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamic acid;2,2,2-trifluoroacetic acid (PubChem CID 68656422) has the molecular formula C24H16F4N4O6 and a molecular weight of 532.41 g/mol. Its IUPAC name is [6-[2-(3-fluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamic acid;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | [6-[2-(3-fluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamic acid;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 68656422 |
| Molecular Formula | C24H16F4N4O6 |
| Molecular Weight | 532.41 g/mol |
| Exact Mass | 532.10 |
| IUPAC Name | [6-[2-(3-fluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamic acid;2,2,2-trifluoroacetic acid |
| SMILES | O=C(O)C(F)(F)F.O=C(O)Nc1nc2ccc(C3(O)c4ccccc4C(=O)N3c3cccc(F)c3)cc2[nH]1 |
| InChI | InChI=1S/C22H15FN4O4.C2HF3O2/c23-13-4-3-5-14(11-13)27-19(28)15-6-1-2-7-16(15)22(27,31)12-8-9-17-18(10-12)25-20(24-17)26-21(29)30;3-2(4,5)1(6)7/h1-11,31H,(H,29,30)(H2,24,25,26);(H,6,7) |
| InChIKey | QBOKFVNXQHYLMS-UHFFFAOYSA-N |
| XLogP | 4.28 |
| TPSA | 155.85 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 532.41 |
| LogP ≤ 5 | 4.28 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 68656422 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.